Biologically Active Small Molecules

11-dehydro-2,3-dinor TXB2 has been identified as a TXB2 metabolite in human urine by GC/MS. The relative abundance is only about one-tenth that of 11-dehydro TXB2, making it unlikely that 11-dehydro-2,3-dinor TXB2 will be used widely as an index of

11-dehydro-2,3-dinor TXB2 has been identified as a TXB2 metabolite in human urine by GC/MS. The relative abundance is only about one-tenth that of 11-dehydro TXB2, making it unlikely that 11-dehydro-2,3-dinor TXB2 will be used widely as an index of

11-deoxy PGE1 is a synthetic analog of PGE1. Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2.

11-deoxy PGE1 is a synthetic analog of PGE1. Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2.

11-deoxy PGE1 is a synthetic analog of PGE1. Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2.

11-deoxy PGE1 is a synthetic analog of PGE1. Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2.

11-deoxy PGE2 is a stable, synthetic analog of PGE2. In contrast to PGE2 which has bronchodilation effects, 11-deoxy PGE2 is a powerful bronchoconstrictor and is 5 to 30 times more potent than PGF2&alpha in the contraction of human respiratory

11-deoxy PGE2 is a stable, synthetic analog of PGE2. In contrast to PGE2 which has bronchodilation effects, 11-deoxy PGE2 is a powerful bronchoconstrictor and is 5 to 30 times more potent than PGF2&alpha in the contraction of human respiratory

11-deoxy PGE2 is a stable, synthetic analog of PGE2. In contrast to PGE2 which has bronchodilation effects, 11-deoxy PGE2 is a powerful bronchoconstrictor and is 5 to 30 times more potent than PGF2&alpha in the contraction of human respiratory

11-deoxy PGF1&alpha is a synthetic analog of PGF1&alpha. In whole animal studies, a dose of 32 mg/kg inhibited gastric acid secretion by 35%.

11-deoxy PGF1&alpha is a synthetic analog of PGF1&alpha. In whole animal studies, a dose of 32 mg/kg inhibited gastric acid secretion by 35%.

11-deoxy PGF1&alpha is a synthetic analog of PGF1&alpha. In whole animal studies, a dose of 32 mg/kg inhibited gastric acid secretion by 35%.